Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

A meta-analysis suggests that the short-term benefits of bisphosphonate therapy likely outweigh the short-term harms for most older postmenopausal women who have osteoporosis. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Citation

Karen Rosenberg. Bisphosphonates Likely Beneficial for Most Older Women with Osteoporosis. The American journal of nursing. 2022 Apr 01;122(4):57

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 35348523

View Full Text